Literature DB >> 20668861

Endocrine pancreatic tumours: which are the most useful MRI sequences?

C Caramella1, C Dromain, T De Baere, B Boulet, M Schlumberger, M Ducreux, E Baudin.   

Abstract

OBJECTIVES: To determine magnetic resonance imaging (MRI) signal and enhancement characteristics of endocrine pancreatic tumours (ETPs) and which MR sequences show them most consistently.
METHODS: Fifty-five consecutive patients with 68 ETPs underwent 1.5-T abdominal MRI comprising T2-weighted, unenhanced T1-weighted and dynamic T1-weighted after injection of gadopentetate dimeglumine sequences. Twenty-one patients underwent diffusion-weighted imaging (DWI). Two radiologists identified the number, location, size, signal and enhancement patterns of ETPs, and determined a confidence scale indicating the presence of tumours on DWI. The results were compared with echo-endoscopy (endoscopic ultrasound) findings.
RESULTS: The detection sensitivity was 95%, similar to that of echo-endoscopy. T2-weighted and T1-weighted sequences at the arterial phase had the highest contrast-to-noise ratio (CNR) median value. On DWI, the mean sensitivity was 65%. The mean apparent diffusion coefficient (ADC) value of ETP was significantly lower than in the normal parenchyma.
CONCLUSION: In suspected ETP, MRI is a sensitive method, similar to echo-endoscopy and could be recommended as the first imaging technique. T2-weighted sequences and T1-weighted sequences in the arterial phase are the optimal pulse sequences. The quantitative assessment of ADC values is a promising tool for the characterisation of pancreatic lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668861     DOI: 10.1007/s00330-010-1840-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection.

Authors:  T Ichikawa; M S Peterson; M P Federle; R L Baron; H Haradome; Y Kawamori; S Nawano; T Araki
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  ADC measurement of abdominal organs and lesions using parallel imaging technique.

Authors:  Takeshi Yoshikawa; Hideaki Kawamitsu; Donald G Mitchell; Yoshiharu Ohno; Yonson Ku; Yasushi Seo; Masahiko Fujii; Kazuro Sugimura
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

3.  High-B-value diffusion-weighted MRI in colorectal cancer.

Authors:  Tomoaki Ichikawa; Sukru Mehmet Erturk; Utarou Motosugi; Hironobu Sou; Hiroshi Iino; Tsutomu Araki; Hideki Fujii
Journal:  AJR Am J Roentgenol       Date:  2006-07       Impact factor: 3.959

4.  MRI of islet cell tumors of the pancreas.

Authors:  Steven Herwick; Frank H Miller; Ana L Keppke
Journal:  AJR Am J Roentgenol       Date:  2006-11       Impact factor: 3.959

5.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease.

Authors:  T Kim; T Murakami; S Takahashi; M Hori; K Tsuda; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

6.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas.

Authors:  Hervé Gouya; Olivier Vignaux; Joelle Augui; Bertrand Dousset; Laurent Palazzo; André Louvel; Stanislas Chaussade; Paul Legmann
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

Review 7.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

Review 8.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 9.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

10.  Population-based study of islet cell carcinoma.

Authors:  James C Yao; Milton P Eisner; Colleen Leary; Cecile Dagohoy; Alexandria Phan; Asif Rashid; Manal Hassan; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

View more
  12 in total

Review 1.  Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours.

Authors:  Andrew D Hopper; Mustafa Jalal; Alia Munir
Journal:  Frontline Gastroenterol       Date:  2018-10-09

2.  Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.

Authors:  Giovanni Foti; Letizia Boninsegna; Massimo Falconi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-07-25       Impact factor: 3.469

3.  Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.

Authors:  Feng Jin; Kai Wang; Ting-Ting Qin; Xin Li; Feng Guo; Gui-Na Ma; Xue-Han Hu; Ping Han
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

4.  Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour.

Authors:  Riccardo Manfredi; Matteo Bonatti; William Mantovani; Rossella Graziani; Diego Segala; Paola Capelli; Giovanni Butturini; Roberto Pozzi Mucelli
Journal:  Eur Radiol       Date:  2013-06-21       Impact factor: 5.315

Review 5.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11

Review 6.  Laparoscopic resection of pancreatic neuroendocrine tumors.

Authors:  Abbas Al-Kurd; Katya Chapchay; Simona Grozinsky-Glasberg; Haggi Mazeh
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 7.  Diagnosis of Pancreatic Neuroendocrine Tumors.

Authors:  Dong Wook Lee; Michelle Kang Kim; Ho Gak Kim
Journal:  Clin Endosc       Date:  2017-11-30

8.  Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.

Authors:  Chuangen Guo; Xiao Chen; Wenbo Xiao; Qidong Wang; Ke Sun; Zhongqiu Wang
Journal:  Onco Targets Ther       Date:  2017-03-07       Impact factor: 4.147

9.  Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group.

Authors:  Rachel P Riechelmann; Rui F Weschenfelder; Frederico P Costa; Aline Chaves Andrade; Alessandro Bersch Osvaldt; Ana Rosa P Quidute; Allan Dos Santos; Ana Amélia O Hoff; Brenda Gumz; Carlos Buchpiguel; Bruno S Vilhena Pereira; Delmar Muniz Lourenço Junior; Duilio Reis da Rocha Filho; Eduardo Antunes Fonseca; Eduardo Linhares Riello Mello; Fabio Ferrari Makdissi; Fabio Luiz Waechter; Francisco Cesar Carnevale; George B Coura-Filho; Gustavo Andrade de Paulo; Gustavo Colagiovanni Girotto; João Evangelista Bezerra Neto; João Glasberg; Jose Claudio Casali-da-Rocha; Juliana Florinda M Rego; Luciana Rodrigues de Meirelles; Ludhmila Hajjar; Marcos Menezes; Marcello D Bronstein; Marcelo Tatit Sapienza; Maria Candida Barisson Villares Fragoso; Maria Adelaide Albergaria Pereira; Milton Barros; Nora Manoukian Forones; Paulo Cezar Galvão do Amaral; Raphael Salles Scortegagna de Medeiros; Raphael L C Araujo; Regis Otaviano França Bezerra; Renata D'Alpino Peixoto; Samuel Aguiar; Ulysses Ribeiro; Tulio Pfiffer; Paulo M Hoff; Anelisa K Coutinho
Journal:  Ecancermedicalscience       Date:  2017-01-26

10.  Homogenously isoattenuating insulinoma on biphasic contrast-enhanced computed tomography: Little benefits of diffusion-weighted imaging for lesion detection.

Authors:  Zhenshan Shi; Xiumei Li; Ruixiong You; Yueming Li; Xianying Zheng; Kamisha Ramen; Vikash Sahadeo Loosa; Dairong Cao; Qunlin Chen
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.